The landscape of blood sugar treatment is evolving with the introduction of transdermal GLP-1 delivery . These novel patches offer a possibly more comfortable alternative to injections for individuals dealing with diabetes 2. These patches deliver a GLP-1 agonist directly through the dermis , cir